Articles related to OPIOIDS
DEA: “Rainbow Fentanyl” a Deliberate Tactic to Target Young People
The colorful fentanyl, known as “rainbow fentanyl,” has been identified in 18 different states and has been found in a variety of forms, including pills, powder, and blocks that resemble sidewalk chalk, according to a press release from the agency. No particular color has been found to have a higher potency through testing. According to the DEA, every shade, shape, and size should be viewed as being exceedingly harmful.
Family Medicine/General Practice September 19th 2022
New Opioid 10 Times Stronger Than Fentanyl Approved Despite Abuse Concerns
Sufentanil sublingual tablet 30 mcg (Dsuvia, AcelRx), an effective novel tablet formulation of the synthetic opioid sufentanil, has been given FDA approval for the management of severe acute pain in adult patients in licensed medically supervised healthcare settings. The medication is administered sublingually in a single-dose, prefilled applicator.
Clinical Pharmacology September 8th 2022
Rebalancing Risk–Benefit With Buprenorphine: An Atypical Opioid Analgesic
1.0 AMA PRA Category 1 Credit™1.0 ACPE contact hour (0.1 CEU) Release Date: May 1, 2022Expiration Date: May 1, 2023 Learning ObjectivesAfter completing this activity, participants should be better able to: Describe the pharmacologic and safety differences between conventional and atypical opioids. Recognize appropriate patients who might benefit from buprenorphine as a first-line opioid analgesic. Understand how to transition opioid therapy from full µ-opioid analgesics to buprenorphine when appropriate.
Clinical Pharmacology August 5th 2022
Complex Persistent Benzodiazepine Dependence—When Benzodiazepine Deprescribing Goes Awry
With fast symptom relief and reinforcing effects, benzodiazepines were once the gold standard for treating insomnia and anxiety. As opioids dominate headlines along with the public health crisis of drug overdose deaths, is it time to reconsider benzodiazepines as a course of treatment?
Psychiatry June 21st 2022
Physician Charged with Murder of Patients for Whom He Provided Comfort Care
The story of “Dr. H,” an up-and-coming physician who was charged with 14 counts of murder in June 2019 after prescribing patients extremely high doses of fentanyl. The prosecution said Dr. H had intended to hasten or cause the deaths of the 14 patients, and it did not matter whether they were severely ill or close to dying. The defense argued the physician was merely relieving the patients’ suffering and that they died from their underlying diseases or being removed from ventilators. Who did the jury agree with?
Hospitalist June 13th 2022
CDC Revised Opioid Prescribing Guideline Falls Short of What People in Pain Need
“The guideline was never intended to set a standard of care in the treatment of pain, much less was it intended to serve as a means to criminally prosecute clinicians. While the new guideline is a substantial improvement, harm from the 2016 guideline will not be easily erased and will require more specific wording than is currently present.” (Requires free registration / login)
Pain Medicine May 3rd 2022